Gilead Sciences (GILD) Other Accumulated Expenses (2011 - 2026)
Gilead Sciences (GILD) recorded Other Accumulated Expenses of $3.7 billion in Q2 2026, up 3.2% from $3.59 billion a year earlier and up 8.8% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences reported Other Accumulated Expenses of $3.95 billion, down 27.7% from FY2024.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $5.46 billion in FY2024 (+6.5%), $5.13 billion in FY2023 (+12.0%), $4.58 billion in FY2022 (-25.5%) and $6.15 billion in FY2021 (+168.7%).
- Quarterly Other Accumulated Expenses has ranged from $3.4 billion in Q1 2026 to $6.15 billion in Q4 2021 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses rose in three of the last eight quarters, with an average decline of 12.6%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 168.7% in Q4 2021, against a decline of 27.7% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.4 billion (Q1 2026), $3.95 billion (Q4 2025) and $3.75 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Bn |
| Mar 31, 2026 | 3.40 Bn |
| Dec 31, 2025 | 3.95 Bn |
| Sep 30, 2025 | 3.75 Bn |
| Jun 30, 2025 | 3.59 Bn |
| Mar 31, 2025 | 4.62 Bn |
| Dec 31, 2024 | 5.46 Bn |
| Sep 30, 2024 | 4.90 Bn |
| Jun 30, 2024 | 4.51 Bn |
| Mar 31, 2024 | 4.46 Bn |
| Dec 31, 2023 | 5.13 Bn |
| Sep 30, 2023 | 5.85 Bn |
| Jun 30, 2023 | 5.81 Bn |
| Mar 31, 2023 | 4.14 Bn |
| Dec 31, 2022 | 4.58 Bn |
| Dec 31, 2021 | 6.15 Bn |
| Dec 31, 2020 | 2.29 Bn |
| Jun 30, 2015 | 1.51 Bn |
| Mar 31, 2015 | 1.44 Bn |
| Dec 31, 2014 | 1.45 Bn |
API Access
Gilead Sciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();